AREV Life Sciences Global Corp. (AREVF)

Market Cap	15.88K -99.7%
Revenue (ttm)	5.33K -96.1%
Net Income	-177.08K
EPS	-0.01
Shares Out	31.76M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	8,875
Open	0.0005
Previous Close	0.0005
Day's Range	0.0005 - 0.0005
52-Week Range	0.0005 - 0.0005
Beta	5.39
RSI	41.35
Earnings Date	n/a

About AREV Life Sciences Global

AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company’s pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-TORE, a product based on organic plant nutrition for patients with overt clinical need for rational enhanced caloric intake and micronutrient suppleme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Michael Withrow
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: AREVF

Financial Performance

In 2022, AREV Life Sciences Global's revenue was 49,113, a decrease of -80.74% compared to the previous year's 254,996. Losses were -1.44 million, 45.8% more than in 2021.

Financial numbers in CAD